CRISPR Therapeutics AG (CRSP)
USD 32.23
(-1.32%)
USD 32.23
(-1.32%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -150.84 Million USD | -569.4% |
| 2022 | 32.13 Million USD | 104.6% |
| 2021 | -698 Million USD | 36.96% |
| 2020 | -1.1 Billion USD | -24.23% |
| 2019 | -891.23 Million USD | -95.17% |
| 2018 | -456.64 Million USD | -90.46% |
| 2017 | -239.75 Million USD | 24.01% |
| 2016 | -315.52 Million USD | -168.24% |
| 2015 | -117.62 Million USD | -12347.09% |
| 2014 | -945 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -472.5 Million USD | -213.24% |
| 2024 Q3 | 1.87 Million USD | 100.74% |
| 2024 Q2 | -253.16 Million USD | 46.42% |
| 2023 Q2 | -199.62 Million USD | -91.69% |
| 2023 FY | -150.84 Million USD | -569.4% |
| 2023 Q1 | -104.13 Million USD | -424.05% |
| 2023 Q4 | -150.84 Million USD | 47.29% |
| 2023 Q3 | -286.17 Million USD | -43.36% |
| 2022 Q1 | -444.92 Million USD | 36.26% |
| 2022 FY | 32.13 Million USD | 104.6% |
| 2022 Q4 | 32.13 Million USD | 112.75% |
| 2022 Q3 | -251.99 Million USD | 0.97% |
| 2022 Q2 | -254.46 Million USD | 42.81% |
| 2021 Q3 | -806.17 Million USD | 44.61% |
| 2021 FY | -698 Million USD | 36.96% |
| 2021 Q2 | -1.45 Billion USD | -36.71% |
| 2021 Q1 | -1.06 Billion USD | 3.85% |
| 2021 Q4 | -698 Million USD | 13.42% |
| 2020 Q2 | -894.84 Million USD | -6.74% |
| 2020 Q3 | -992.2 Million USD | -10.88% |
| 2020 Q4 | -1.1 Billion USD | -11.59% |
| 2020 FY | -1.1 Billion USD | -24.23% |
| 2020 Q1 | -838.31 Million USD | 5.94% |
| 2019 Q4 | -891.23 Million USD | -51.55% |
| 2019 FY | -891.23 Million USD | -95.17% |
| 2019 Q2 | -385.8 Million USD | 3.77% |
| 2019 Q3 | -588.08 Million USD | -52.43% |
| 2019 Q1 | -400.92 Million USD | 12.2% |
| 2018 Q3 | -487.29 Million USD | -52.4% |
| 2018 Q4 | -456.64 Million USD | 6.29% |
| 2018 FY | -456.64 Million USD | -90.46% |
| 2018 Q1 | -341.76 Million USD | -42.55% |
| 2018 Q2 | -319.73 Million USD | 6.45% |
| 2017 FY | -239.75 Million USD | 24.01% |
| 2017 Q1 | -288.87 Million USD | 8.45% |
| 2017 Q2 | -272.26 Million USD | 5.75% |
| 2017 Q3 | -253.51 Million USD | 6.88% |
| 2017 Q4 | -239.75 Million USD | 5.43% |
| 2016 Q2 | -246.84 Million USD | -23.06% |
| 2016 Q1 | -200.6 Million USD | -70.54% |
| 2016 FY | -315.52 Million USD | -168.24% |
| 2016 Q4 | -315.52 Million USD | -38.01% |
| 2016 Q3 | -228.61 Million USD | 7.39% |
| 2015 Q4 | -117.62 Million USD | 0.0% |
| 2015 FY | -117.62 Million USD | -12347.09% |
| 2014 FY | -945 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -169.655% |
| Alkermes plc | -166.73 Million USD | 9.532% |
| Agenus Inc. | 274.13 Million USD | 155.026% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 108.067% |
| Aptorum Group Limited | 1.35 Million USD | 11215.688% |
| Ardelyx, Inc. | 34.51 Million USD | 537.08% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 3624.416% |
| Bicycle Therapeutics plc | -481.46 Million USD | 68.67% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 517.125% |
| ChromaDex Corporation | -24.04 Million USD | -527.266% |
| Chimerix, Inc. | -25.51 Million USD | -491.155% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 2264.801% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -537.095% |
| Precision BioSciences, Inc. | -85.41 Million USD | -76.613% |
| Dyadic International, Inc. | -6.37 Million USD | -2265.046% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -846.746% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2067.971% |
| Lantern Pharma Inc. | -21.7 Million USD | -595.033% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -36.466% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1665.678% |
| Incyte Corporation | -3.17 Billion USD | 95.249% |
| IO Biotech, Inc. | -140.69 Million USD | -7.211% |
| Jaguar Health, Inc. | 29.39 Million USD | 613.235% |
| Novavax, Inc. | -298.29 Million USD | 49.431% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 2926.401% |
| Opthea Limited | 28.15 Million USD | 635.72% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -798.475% |
| ContextLogic Inc. | -232 Million USD | 34.981% |
| MiMedx Group, Inc. | -33.9 Million USD | -344.957% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1579.598% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -6410.282% |
| NextCure, Inc. | -6.47 Million USD | -2228.933% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -198.697% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -2264.712% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1340.168% |
| Vaxcyte, Inc. | -368.22 Million USD | 59.035% |
| PDS Biotechnology Corporation | -32.7 Million USD | -361.174% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 973.047% |
| Pharming Group N.V. | 109.8 Million USD | 237.377% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -767.125% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 13.916% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -714.504% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -714.504% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -2024.577% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -2474.147% |
| Acelyrin, Inc. | -216.9 Million USD | 30.455% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -2588.731% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -8649.71% |
| Summit Therapeutics Inc. | 34.67 Million USD | 535.038% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -2117.331% |
| Senti Biosciences, Inc. | 1.74 Million USD | 8769.253% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 18.289% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -94.762% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -2388.37% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 151294.259% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 24119.904% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -28.877% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 10.336% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 236.056% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -1885.848% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -16.831% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 2287.872% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 37.761% |
| Immix Biopharma, Inc. | -17.5 Million USD | -761.489% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 52.37% |
| MEI Pharma, Inc. | -3.7 Million USD | -3971.39% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1305.699% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 193.263% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 642.745% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2067.971% |
| Precigen, Inc. | -481 Thousand USD | -31260.707% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1171.266% |
| AlloVir, Inc. | -62.69 Million USD | -140.613% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -171.236% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 344.616% |
| ImmuCell Corporation | 10.99 Million USD | 1472.496% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 2.141% |
| Onconetix, Inc. | 5.33 Million USD | 2929.35% |
| PureTech Health plc | -167.19 Million USD | 9.78% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -395.223% |
| Elevation Oncology, Inc. | -19.11 Million USD | -689.021% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -2972.825% |
| Seer, Inc. | -4.24 Million USD | -3457.665% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -527.553% |
| Innoviva, Inc. | 255.56 Million USD | 159.025% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -170.022% |
| ESSA Pharma Inc. | -33.62 Million USD | -348.655% |
| GlycoMimetics, Inc. | -40.98 Million USD | -268.054% |
| GT Biopharma, Inc. | -1.02 Million USD | -14674.241% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -122.541% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 346.249% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -12.505% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -988.662% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -422.461% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -200134.954% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -388.773% |
| Aptose Biosciences Inc. | -8.19 Million USD | -1740.728% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -4720.842% |
| Soligenix, Inc. | -4.95 Million USD | -2946.391% |
| Century Therapeutics, Inc. | 847 Thousand USD | 17909.327% |
| Kura Oncology, Inc. | -20.11 Million USD | -649.801% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -268.58% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -1696.201% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 8380.475% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -4618.33% |
| Autolus Therapeutics plc | -186.59 Million USD | 19.161% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -205.949% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 45.305% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 540.192% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 191.773% |
| GRI Bio, Inc. | -1.79 Million USD | -8308.305% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1579.219% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -353.574% |
| IGM Biosciences, Inc. | -72.6 Million USD | -107.758% |
| INmune Bio, Inc. | -25.41 Million USD | -493.621% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 199.93% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -197.765% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -828.313% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -5128.73% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 496.804% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -266.262% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 573.091% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 139.911% |
| Verastem, Inc. | -37.27 Million USD | -304.649% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -1562.57% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -190.858% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -896.663% |
| Histogen Inc. | -7.48 Million USD | -1914.759% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -598.136% |
| Surrozen, Inc. | -32.66 Million USD | -361.808% |
| Organovo Holdings, Inc. | -1.5 Million USD | -9909.622% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3488.567% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 895.587% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 5866.246% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 3729.572% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1699.813% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -247.233% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -934.825% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 52.383% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -20790.923% |
| Apollomics, Inc. | -27.39 Million USD | -450.63% |
| Amarin Corporation plc | -191.04 Million USD | 21.04% |
| Mesoblast Limited | 55.96 Million USD | 369.544% |
| Turnstone Biologics Corp. | -14.58 Million USD | -934.318% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -496.414% |
| Synaptogenix, Inc. | -28.66 Million USD | -426.298% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -16015.919% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 409.54% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -17397.613% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -1976.016% |
| Exelixis, Inc. | -73.05 Million USD | -106.496% |
| Better Therapeutics, Inc. | -860 Thousand USD | -17440.116% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -528.181% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 37.505% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 20593.407% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -1927.995% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 12129.107% |
| Gritstone bio, Inc. | 39.49 Million USD | 481.983% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -79.362% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -5630.888% |
| Avid Bioservices, Inc. | 169.72 Million USD | 188.875% |
| Insmed Incorporated | 721.62 Million USD | 120.904% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1550.11% |
| MediWound Ltd. | -5.32 Million USD | -2734.367% |
| OmniAb, Inc. | 9.2 Million USD | 1739.085% |
| Alector, Inc. | -35.63 Million USD | -323.282% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 275.46% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -2960.978% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1239.399% |
| Zai Lab Limited | -775 Million USD | 80.536% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 144.294% |
| Aura Biosciences, Inc. | -21.52 Million USD | -600.79% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -82.887% |
| Immunic, Inc. | -45.34 Million USD | -232.697% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 21.929% |
| Veracyte, Inc. | -203.82 Million USD | 25.993% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 123.633% |
| FibroGen, Inc. | 56.76 Million USD | 365.727% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1793.936% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -5235.714% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -7185.973% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 103.286% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -4414.966% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 9.11% |
| TG Therapeutics, Inc. | 17.86 Million USD | 944.502% |
| Galecto, Inc. | -21.21 Million USD | -610.996% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -534.202% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 109.612% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -516.398% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1210.898% |
| XBiotech Inc. | -200.02 Million USD | 24.586% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -79.362% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 3431.383% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -327.771% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -95.35% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 2750.589% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 11.484% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -63.298% |
| Vaxxinity, Inc. | 10.13 Million USD | 1588.798% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 120.488% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1300.922% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -128.706% |
| NexImmune, Inc. | -3.13 Million USD | -4713.726% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -4268.934% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -898.217% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -456.624% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1580.527% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -120987.698% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -271.796% |
| Ainos, Inc. | 4.07 Million USD | 3799.06% |
| Pluri Inc. | 22.82 Million USD | 760.76% |
| Prothena Corporation plc | -608.34 Million USD | 75.204% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -27.021% |
| Celularity Inc. | 65.19 Million USD | 331.393% |
| Rallybio Corporation | -24.1 Million USD | -525.861% |
| Cue Biopharma, Inc. | -33.81 Million USD | -346.036% |
| MeiraGTx Holdings plc | -40.3 Million USD | -274.287% |
| Omeros Corporation | 331.17 Million USD | 145.548% |
| Humacyte, Inc. | -22.48 Million USD | -570.84% |
| Immunocore Holdings plc | -358.59 Million USD | 57.934% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -513.815% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -388.156% |
| Blueprint Medicines Corporation | 702.83 Million USD | 121.462% |
| CalciMedica, Inc. | -5.53 Million USD | -2627.758% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 19.857% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1376.846% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -276.764% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -353.628% |
| Pulmatrix, Inc. | -10.41 Million USD | -1348.066% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -2423.758% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -295.483% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -35.406% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -151.643% |
| Cytokinetics, Incorporated | 642.37 Million USD | 123.482% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -2490.503% |
| Nutriband Inc. | -251.65 Thousand USD | -59840.713% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -342.114% |
| Vor Biopharma Inc. | 4.3 Million USD | 3608.023% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 97.501% |
| Evogene Ltd. | -19.63 Million USD | -668.285% |
| ProKidney Corp. | -56.23 Million USD | -168.236% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -209.922% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1533.019% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 111.06% |
| CorMedix Inc. | -43.05 Million USD | -250.375% |
| BioLineRx Ltd. | 7.33 Million USD | 2156.23% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -449.226% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 426.879% |
| Atai Life Sciences N.V. | -28.55 Million USD | -428.206% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 6862.746% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -561.137% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 950.55% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -100.928% |
| MediciNova, Inc. | -50.78 Million USD | -197.035% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -91.416% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -670471.238% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2237.744% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 24.51% |
| Biomea Fusion, Inc. | -166.57 Million USD | 9.44% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 15.717% |
| Mereo BioPharma Group plc | -51.46 Million USD | -193.079% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -59.045% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 48.65% |
| Absci Corporation | -72.59 Million USD | -107.781% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3403.657% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 35.656% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -60.114% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -57.629% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -286.059% |
| Allakos Inc. | -24.97 Million USD | -503.984% |
| Imunon, Inc. | -4.21 Million USD | -3479.741% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -923.233% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -11.407% |
| BioAtla, Inc. | -109.01 Million USD | -38.376% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 20593.407% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -15964.43% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1360.613% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -611.432% |
| XOMA Corporation | -29 Million USD | -420.155% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -810.9% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1573.081% |
| aTyr Pharma, Inc. | -7.44 Million USD | -1925.037% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -21.028% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 27.536% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -84.454% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -62.613% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -17456.775% |
| Akari Therapeutics, Plc | -3.84 Million USD | -3823.147% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 9394.838% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 110.924% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -12595.948% |
| UroGen Pharma Ltd. | 4.39 Million USD | 3535.322% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 232.925% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 209717.576% |
| Orgenesis Inc. | 21.78 Million USD | 792.458% |
| Entera Bio Ltd. | -10.62 Million USD | -1319.183% |
| GH Research PLC | -78.07 Million USD | -93.2% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -576.799% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -465.831% |
| Xencor, Inc. | 29.64 Million USD | 608.855% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -7557.837% |
| Replimune Group, Inc. | 1.41 Million USD | 10783.074% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -61492.516% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -19.323% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -12595.948% |
| Portage Biotech Inc. | -4.98 Million USD | -2928.408% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -670471.238% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -128.131% |
| OncoCyte Corporation | -6.56 Million USD | -2198.415% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 16908.872% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -3211.168% |
| Purple Biotech Ltd. | -14.13 Million USD | -966.947% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -534.976% |
| scPharmaceuticals Inc. | -6.54 Million USD | -2204.736% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -803.687% |
| HilleVax, Inc. | -165.48 Million USD | 8.847% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -5843.459% |
| Tharimmune, Inc. | -10.93 Million USD | -1279.425% |
| Genprex, Inc. | -6.73 Million USD | -2138.844% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 59.099% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -70.523% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -10666.952% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -4447.707% |
| OKYO Pharma Limited | -826.84 Thousand USD | -18143.377% |
| Savara Inc. | 153 Thousand USD | 98691.503% |
| Curis, Inc. | -23.88 Million USD | -531.494% |
| Daré Bioscience, Inc. | -5.15 Million USD | -2824.537% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -19338.488% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -2329.849% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 12829.536% |
| BeiGene, Ltd. | -2.25 Billion USD | 93.305% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1322.555% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 75.198% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 18.72% |
| Erasca, Inc. | -37.21 Million USD | -305.323% |
| bluebird bio, Inc. | 108.57 Million USD | 238.937% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -11612.541% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 139.827% |
| DBV Technologies S.A. | -126.98 Million USD | -18.789% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -11612.541% |
| Moderna, Inc. | -2.9 Billion USD | 94.811% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1357.158% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1287.974% |
| Molecular Templates, Inc. | 707 Thousand USD | 21435.926% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -380.842% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 143.52% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -83.818% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -64.445% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -367.418% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -338.809% |
| MacroGenics, Inc. | -66.98 Million USD | -125.192% |
| RenovoRx, Inc. | -1.17 Million USD | -12759.761% |
| Adicet Bio, Inc. | -138.78 Million USD | -8.688% |
| Prime Medicine, Inc. | -27.94 Million USD | -439.87% |
| Aditxt, Inc. | 18.12 Million USD | 932.437% |
| Adagene Inc. | -87.62 Million USD | -72.144% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3521.357% |
| Quantum-Si incorporated | -118.55 Million USD | -27.234% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 518.956% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -1918.213% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -210.963% |
| SciSparc Ltd. | -2.06 Million USD | -7204.843% |
| Vericel Corporation | 1.27 Million USD | 11912.451% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1157.912% |
| Minerva Neurosciences, Inc. | 41 Million USD | 467.877% |
| Generation Bio Co. | 31.44 Million USD | 579.665% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 13.982% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -387.808% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 229.377% |
| Invivyd, Inc. | -198.47 Million USD | 23.998% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -67.104% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -6191.268% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -113.088% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -2110.183% |
| 2seventy bio, Inc. | 181.71 Million USD | 183.012% |
| ADMA Biologics, Inc. | 90.06 Million USD | 267.483% |
| Clene Inc. | 3.34 Million USD | 4616.317% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -1560.794% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -601.246% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2237.744% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 56.166% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -480.18% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 184.904% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -3586.729% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 3115.694% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -2795.853% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -15.764% |
| Evaxion Biotech A/S | 5.28 Million USD | 2953.215% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -34.003% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -14.909% |
| Trevena, Inc. | 2.25 Million USD | 6780.469% |
| Surrozen, Inc. | -32.66 Million USD | -361.808% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -192.846% |
| Cingulate Inc. | 3.08 Million USD | 4993.302% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -5036.023% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 2198.859% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1523.521% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -90.166% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -14.753% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -42.924% |
| Clearmind Medicine Inc. | -3.94 Million USD | -3725.993% |
| Kronos Bio, Inc. | -36.05 Million USD | -318.386% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1703.199% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 10445.121% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -178.025% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1146.343% |
| ImmunityBio, Inc. | 618.22 Million USD | 124.4% |
| Korro Bio, Inc. | -132.94 Million USD | -13.466% |
| Kineta, Inc. | -4.54 Million USD | -3221.845% |
| BioVie Inc. | -17.73 Million USD | -750.677% |
| Codexis, Inc. | -43.27 Million USD | -248.605% |
| Celularity Inc. | 65.19 Million USD | 331.393% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -4660.019% |
| Celcuity Inc. | 6.78 Million USD | 2323.702% |
| Virax Biolabs Group Limited | -3.36 Million USD | -4382.838% |
| Cibus, Inc. | -8.07 Million USD | -1767.356% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -3466.919% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 3400.766% |
| IN8bio, Inc. | -16.38 Million USD | -820.404% |
| Kodiak Sciences Inc. | -103.87 Million USD | -45.218% |
| Annexon, Inc. | -193.75 Million USD | 22.147% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 419113.889% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -762.021% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -4193.908% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 114.308% |
| Eyenovia, Inc. | 1.25 Million USD | 12084.171% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 660.658% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -4551.403% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -353.71% |
| Arcellx, Inc. | -296.95 Million USD | 49.203% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -673.326% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -156.212% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -627.771% |
| Moolec Science SA | 117.61 Thousand USD | 128352.109% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -292.836% |
| Geron Corporation | 14.76 Million USD | 1121.916% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -297.819% |
| Royalty Pharma plc | 5.65 Billion USD | 102.666% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -6.664% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -2058.189% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -2712.772% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -7.187% |
| Humacyte, Inc. | -22.48 Million USD | -570.84% |
| Structure Therapeutics Inc. | -124.33 Million USD | -21.318% |
| 89bio, Inc. | -289.05 Million USD | 47.814% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -497.595% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -8360.179% |
| Genelux Corporation | -6.89 Million USD | -2086.476% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -385.672% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 280.439% |
| Notable Labs, Ltd. | -9.77 Million USD | -1443.014% |
| Liquidia Corporation | -80.17 Million USD | -88.142% |
| Mustang Bio, Inc. | -3.73 Million USD | -3937.607% |
| Immunovant, Inc. | -635.22 Million USD | 76.253% |
| Quantum-Si incorporated | -118.55 Million USD | -27.234% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -758.831% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -3540.961% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 1979.22% |
| Acasti Pharma Inc. | -23 Million USD | -555.705% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -4379.796% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -828.313% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -9.514% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -4740.42% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -578.504% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -712.349% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 10.889% |
| PepGen Inc. | -60.67 Million USD | -148.632% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -556.533% |
| United Therapeutics Corporation | -507.7 Million USD | 70.289% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -688.691% |
| Solid Biosciences Inc. | -47.75 Million USD | -215.906% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -17397.613% |
| Immuneering Corporation | -54.94 Million USD | -174.549% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3488.567% |
| Silo Pharma, Inc. | -3.52 Million USD | -4180.131% |
| Belite Bio, Inc | -87.27 Million USD | -72.847% |
| XOMA Corporation | -29 Million USD | -420.155% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -113.368% |
| Bionomics Limited | 227 Million USD | 166.449% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -29.723% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -5855.191% |
| uniQure N.V. | -102.95 Million USD | -46.521% |
| Cassava Sciences, Inc. | -121.13 Million USD | -24.525% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3521.357% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 468.355% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1161.14% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -4775.089% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 142406.604% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -4551.403% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1793.936% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -1934.048% |
| Altimmune, Inc. | -134.48 Million USD | -12.163% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 176.159% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -5855.191% |
| Compugen Ltd. | -12.9 Million USD | -1068.979% |
| Peak Bio, Inc. | 10.34 Million USD | 1558.827% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -53202.12% |
| Benitec Biopharma Inc. | -50.58 Million USD | -198.219% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -44.573% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 867.854% |
| Zura Bio Limited | -99.8 Million USD | -51.138% |
| PolyPid Ltd. | 6.17 Million USD | 2544.814% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 303.515% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 867.854% |
| Instil Bio, Inc. | 75.35 Million USD | 300.171% |
| argenx SE | -2.02 Billion USD | 92.565% |
| Immunome, Inc. | -97.02 Million USD | -55.464% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -570.571% |
| Verona Pharma plc | -220.44 Million USD | 31.572% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -110.257% |
| Shattuck Labs, Inc. | -121.42 Million USD | -24.23% |
| CervoMed Inc. | -7.79 Million USD | -1835.686% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 18.682% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -3349.463% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -14.502% |
| Moolec Science SA | 117.61 Thousand USD | 128352.109% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -6492.942% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1048.807% |
| AnaptysBio, Inc. | -18.15 Million USD | -731.056% |
| Design Therapeutics, Inc. | -18.15 Million USD | -731.102% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -114.326% |
| NeurAxis, Inc. | 145.7 Thousand USD | 103631.229% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1442.993% |
| Lumos Pharma, Inc. | -28.49 Million USD | -429.411% |
| Achilles Therapeutics plc | -126.92 Million USD | -18.847% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -110.257% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -22904.133% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -626.13% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 10445.121% |
| Nutriband Inc. | -251.65 Thousand USD | -59840.713% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1045.281% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -1927.487% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 144.34% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 735.538% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 66.289% |
| Palisade Bio, Inc. | -12.06 Million USD | -1150.477% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -7.508% |
| Beam Therapeutics Inc. | -262.72 Million USD | 42.584% |
| Neurogene Inc. | -131.95 Million USD | -14.315% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 791.442% |
| AEON Biopharma, Inc. | -4.88 Million USD | -2991.086% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 60.008% |
| Sesen Bio, Inc. | -112.55 Million USD | -34.021% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -51.056% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -6324.97% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -286.524% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -81.126% |
| Athira Pharma, Inc. | -88.99 Million USD | -69.491% |
| Vaccinex, Inc. | -1.28 Million USD | -11611.568% |
| HCW Biologics Inc. | 2.85 Million USD | 5380.438% |
| XOMA Corporation | -29 Million USD | -420.155% |
| Nektar Therapeutics | 210.24 Million USD | 171.749% |
| Arvinas, Inc. | -313.8 Million USD | 51.93% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 9394.838% |
| Merus N.V. | -192.88 Million USD | 21.795% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 351.471% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -2074.186% |
| Rezolute, Inc. | -68.16 Million USD | -121.284% |
| Clene Inc. | 3.34 Million USD | 4616.317% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1043.892% |
| BeyondSpring Inc. | -13.75 Million USD | -996.656% |
| Synlogic, Inc. | -6.68 Million USD | -2156.47% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 13402.028% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -1684.092% |
| Peak Bio, Inc. | 10.34 Million USD | 1558.827% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -83.02% |
| Krystal Biotech, Inc. | -350.23 Million USD | 56.93% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 221.527% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 10.74% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -4677.894% |
| MannKind Corporation | 143.89 Million USD | 204.827% |
| Ikena Oncology, Inc. | -109.15 Million USD | -38.192% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -1892.405% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -355.725% |
| Gossamer Bio, Inc. | 180.35 Million USD | 183.638% |
| CohBar, Inc. | -5.93 Million USD | -2443.447% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -407.076% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3403.657% |
| Legend Biotech Corporation | -949.39 Million USD | 84.112% |
| Mural Oncology plc | -255.84 Million USD | 41.04% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 568.245% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -3102.217% |
| Disc Medicine, Inc. | -358.28 Million USD | 57.898% |
| Champions Oncology, Inc. | 4.81 Million USD | 3234.767% |
| REGENXBIO Inc. | 54.76 Million USD | 375.425% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -55995.602% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 0.119% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1573.823% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -86.96% |
| Vaxart, Inc. | -8.24 Million USD | -1730.421% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -200.608% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -18.621% |
| Cellectis S.A. | -43.85 Million USD | -243.963% |
| Longeveron Inc. | -2.9 Million USD | -5087.242% |
| Repare Therapeutics Inc. | -107.85 Million USD | -39.855% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 115.577% |
| Inozyme Pharma, Inc. | 12 Million USD | 1356.623% |
| Revolution Medicines, Inc. | -608.2 Million USD | 75.198% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -12163.821% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 43.102% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -0.515% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -864.051% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -20284.459% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.423% |
| Denali Therapeutics Inc. | -74.86 Million USD | -101.489% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1157.912% |
| Veru Inc. | 4.77 Million USD | 3255.774% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1241.321% |
| Cingulate Inc. | 3.08 Million USD | 4993.302% |
| Passage Bio, Inc. | 4.58 Million USD | 3389.967% |
| Context Therapeutics Inc. | -14.44 Million USD | -943.923% |
| Exicure, Inc. | 5.84 Million USD | 2678.988% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 34.522% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -281.211% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1061.347% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -156.448% |
| Nuvalent, Inc. | -335.38 Million USD | 55.024% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 8797.54% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -102.525% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -1596.794% |
| OmniAb, Inc. | 9.2 Million USD | 1739.085% |
| Anew Medical, Inc. | 1.43 Million USD | 10630.449% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1020.811% |
| Lipocine Inc. | -4.75 Million USD | -3072.617% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -37.347% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1090.381% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -197.765% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 705.998% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -2144.383% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -129.154% |
| Ocugen, Inc. | -32.52 Million USD | -363.839% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -76.272% |
| Q32 Bio Inc. | -37.94 Million USD | -297.504% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -23919.904% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1014.975% |
| Equillium, Inc. | -22.39 Million USD | -573.656% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -489.976% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -362.335% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -60745.451% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 212.536% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 4816.854% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 46027.579% |
| Dominari Holdings Inc. | 195 Thousand USD | 77456.41% |
| Edesa Biotech, Inc. | -5.26 Million USD | -2764.013% |
| vTv Therapeutics Inc. | -8.91 Million USD | -1591.656% |
| Bio-Techne Corporation | 267.74 Million USD | 156.339% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -830.625% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -27.733% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -1695.133% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1092.356% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 38.461% |
| Nkarta, Inc. | 57.29 Million USD | 363.259% |
| BioCardia, Inc. | 212 Thousand USD | 71253.302% |
| Iterum Therapeutics plc | 13.43 Million USD | 1222.526% |